Articles

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group

Hopital Saint Louis, Université Paris Diderot, France
Centre Hopitalo-Universitaire Lyon, France
Centre Hopitalo-Universitaire Nancy, France
Hopital Saint Louis, Université Paris Diderot, France
Service d’Hématologie CHUV Lausanne, Switzerland
Institut Paoli Calmette, Marseille, France
Rennes University Hospital, France
Toulouse University Hospital, France
Bordeaux University Hospital, France
Limoges University Hospital, France
Besancon University Hospital, France
Bobigny University Hospital, France
Clermont-Ferrand University Hospital, France
Centre Hopitalo-Universitaire Vaudois, Switzerland
Nantes University Hospital, France
Institut Gustave Roussy, Villejuif, France
Hopital Saint Louis, Université Paris Diderot, France
Hopital Saint Louis, Université Paris Diderot, France
Hopital Saint Louis, Université Paris Diderot, France
Hopital Saint Louis, Université Paris Diderot, France
Vol. 103 No. 12 (2018): December, 2018 https://doi.org/10.3324/haematol.2018.198614